Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB/ SE0000872095 /
SOBI/S
2024-03-28 12:09:14 PM
|
Chg.
-3.40
|
Volume |
Bid12:09:15 PM |
Ask12:09:29 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
267.80SEK
|
-1.25%
|
24,794 Turnover: 2.72 mill. |
267.80Bid Size: 130 |
268.00Ask Size: 394 |
83.59 bill.SEK |
- |
30.25 |
Fundamentals
|
FY 2022 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
8.92 SEK |
-1.76% |
EPS Diluted: |
- SEK |
-2.10% |
Revenues per Share: |
60.65 SEK |
19.95% |
Book Value per Share: |
85.62 SEK |
13.32% |
Cash Flow per Share: |
15.06 SEK |
-15.46% |
Dividend per Share: |
- SEK |
- |
Total |
in mill. |
|
Revenues: |
18,790.00 SEK |
21.00% |
Net Income: |
2,638.00 SEK |
-1.53% |
Operating Cash Flow: |
4,665.00 SEK |
- |
Cash and Cash Equivalents: |
1,361.00 SEK |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
30.25 |
24.18 |
P/S Ratio: |
4.45 |
3.56 |
P/BV ratio: |
3.15 |
2.52 |
P/CF Ratio: |
17.92 |
14.32 |
PEG: |
-17.17 |
-13.72 |
Earnings Yield: |
3.31% |
4.14% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
83.59 bill. SEK |
66.82 bill. SEK |
Free Float Market Cap.: |
- SEK |
- SEK |
Market Cap. / Employee: |
53.72 mill. SEK |
42.95 mill. SEK |
Shares Outstanding: |
309.8 mill. |
|
Profitability
Gross Profit Margin: |
74.58% |
EBIT Margin: |
20.29% |
Net Profit Margin: |
14.04% |
Return on Equity: |
9.95% |
Return on Assets: |
5.03% |
Financial Strength
Liquidity I / Cash Ratio: |
9.16% |
Liquidity II / Quick Ratio: |
44.49% |
Liquidity III / Current Ratio: |
75.45% |
Debt / Equity Ratio: |
97.91% |
Dynam. Debt / Equity Ratio: |
556.72% |
Efficiency
Employees: |
1,556 |
Personal Expenses / Employee: |
- SEK |
Revenues / Employee: |
12,075,835.48 SEK |
Net Income / Employee: |
1,695,372.75 SEK |
Total Assets / Employee: |
33,737,789.20 SEK |
* Fiscal Year End: |
2022-12-31 |
Accounting Standard: |
IFRS |